Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Lead Data Inc.

Market Cap 539M 17.08M 14.72M 13.55M 12.71M 23.87M 1.61B 24.11M 160M 62.55M 790M 64.08M 62.73M 2.73B P/E Ratio 2024
-3.97x
P/E Ratio 2025 -12.3x
Enterprise Value 568M 18M 15.51M 14.28M 13.39M 25.16M 1.7B 25.41M 169M 65.93M 833M 67.55M 66.12M 2.88B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 2022-08-16
Director of Finance/CFO - 2022-06-09
Corporate Officer/Principal - 2022-06-09
Director TitleAgeSince
Director/Board Member - 2019-06-09
Chairman - 2022-08-16
Director/Board Member - 2022-06-09
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%-4.29% 17.04M
-0.25%+3.97%+14.68%+7.07% 9.26B
+0.65%-3.10% - - 1.33B
+0.09%+5.72%+10.11%-11.02% 1.22B
-1.91%-0.51%-12.35%-28.29% 965M
+0.33%-2.25%+82.31%+48.29% 713M
-0.33%-4.90%-13.13% - 618M
+3.33%+59.67%+101.50%+151.88% 378M
-0.14%-2.66%-13.72%-12.14% 378M
-8.56%+20.59%-61.17%-84.08% 255M
Average -1.53%+6.07%+12.03%+8.43% 1.51B
Weighted average by Cap. -0.09%+4.54%+14.82%+6.87%

Financials

2024 2025
Net sales 15.47M 490K 423K 389K 365K 685K 46.33M 692K 4.6M 1.8M 22.69M 1.84M 1.8M 78.51M 111M 3.51M 3.02M 2.78M 2.61M 4.9M 332M 4.95M 32.9M 12.85M 162M 13.17M 12.89M 562M
Net income -134M -4.24M -3.65M -3.36M -3.16M -5.93M -401M -5.99M -39.77M -15.53M -196M -15.91M -15.58M -679M -44.02M -1.4M -1.2M -1.11M -1.04M -1.95M -132M -1.97M -13.08M -5.11M -64.57M -5.24M -5.13M -223M
Net Debt -16.95M -537K -463K -426K -400K -751K -50.78M -759K -5.04M -1.97M -24.87M -2.02M -1.97M -86.06M 29.12M 923K 796K 732K 687K 1.29M 87.23M 1.3M 8.66M 3.38M 42.72M 3.46M 3.39M 148M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!